Screener
Aurinia Pharmaceuticals AUPH Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Intangible assets, net | 3,378 | 3,761 |
| Operating right-of-use lease assets | 1,518 | 3,596 |
| Property and equipment, net | 1,862 | 2,111 |
| Other noncurrent assets | 93 | 93 |
| Total assets | $792,262 | $751,587 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,735 | $3,313 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's deferred tax assets and other non-current assets?
- Aurinia Pharmaceuticals (AUPH) reported deferred tax assets and other non-current assets of $93K in Q2 2026.
- How has Aurinia Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Aurinia Pharmaceuticals's deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $93K to $93K.
- What is the long-term trend for Aurinia Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's deferred tax assets and other non-current assets has grown at a -17.7% compound annual growth rate (CAGR), from $247K to $93K.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Aurinia Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude